CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH CIRRHOSIS DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN SWEDEN

被引：0
|
作者：
Shang, Ying [1 ]
Zhang, Xiao [2 ]
Fernandes, Gail [2 ]
Melaragno, Matthew [2 ]
Engel, Samuel [2 ]
Vessby, Johan [3 ]
Ekstedt, Mattias [4 ]
Hagstrom, Hannes [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Merck & Co Inc, Rahway, NJ USA
[3] Uppsala Univ Hosp, Uppsala, Sweden
[4] Linkoping Univ, Linkoping, Sweden
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1085
引用
收藏
页码：S821 / S822
页数：2
相关论文
共 50 条
  • [41] Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Hamamah, Sevag
    Iatcu, Oana C.
    Covasa, Mihai
    NUTRIENTS, 2025, 17 (01)
  • [42] Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights
    Aggeletopoulou, Ioanna
    Tsounis, Efthymios P.
    Triantos, Christos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [43] Effect of statin therapy in patients with obesity and cirrhosis secondary to metabolic dysfunction-associated steatotic liver disease (MASLD) on pre-liver transplant mortality
    Patel, Ami
    Cooper, Katherine
    Coletta, Alessandro
    Devuni, Deepika
    JOURNAL OF HEPATOLOGY, 2024, 80 : S603 - S603
  • [44] Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials
    Park, Sarah
    Wollstein, Yael
    Hutchison, Alan L.
    Paul, Sonali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1393 - S1393
  • [45] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [46] CLINICAL MANAGEMENT OF DISCREPANCIES BETWEEN FIB-4 AND LIVER STIFFNESS MEASUREMENT IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Rabbat, Joseph
    Lee, Hye Won
    Yip, Terry Cheuk-Fung
    Lin, Huapeng
    Tsochatzis, Emmanuel
    Petta, Salvatore
    Bugianesi, Elisabetta
    Yoneda, Masato
    Zheng, Ming-Hua
    Hagstrom, Hannes
    Boursier, Jerome
    Calleja, Jose Luis
    Goh, George Boon-Bee
    Chan, Wah Kheong
    Gallego-Duran, Rocio
    Sanyal, Arun
    de Ledinghen, Victor
    Newsome, Philip
    Fan, Jian-Gao
    Castera, Laurent
    Lai, Michelle
    Fournier, Celine
    Wong, Grace
    Pennisi, Grazia
    Armandi, Angelo
    Nakajima, Atsushi
    Liu, Wen-Yue
    Shang, Ying
    Saint Loup, Marc De
    Llop, Elba
    Teh, Kevin
    Romero, Carmen Lara
    Asgharpour, Amon
    Mahgoub, Sara
    Chan, Mandy
    Canivet, Clemence
    Romero-Gomez, Manuel
    Kim, Seung Up
    HEPATOLOGY, 2024, 80 : S566 - S567
  • [47] Metabolic dysfunction-associated steatotic liver disease in adults
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
  • [48] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [49] Metabolic dysfunction-associated steatotic liver disease in adults
    Huang, Daniel Q.
    Wong, Vincent W. S.
    Rinella, Mary E.
    Boursier, Jerome
    Lazarus, Jeffrey V.
    Yki-Jarvinen, Hannele
    Loomba, Rohit
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
  • [50] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
12345